Responsible for sales related to instruments and lab services supporting spray characterization of OINDP products.

Abazyme provides recombinant protein development solutions services. Our core capabilities include proprietary antibody development, antibody gene sequencing or gene sequencing for the protein of interest, vector development, transfection services, antibody characterization and comparison between native and recombinant construct as well as research scale production capability.

Experienced Business Development Professional assisting lifesciences companies establish or build customer base for services and products at Biotech and Pharamaceutical companies.

SeqLL (www.SeqLL.com) is a service and instrumentation provider for RNA and specialty DNA sequencing related to biomarker discovery, biomarker validation, early risk or disease identification for oncology, inflammation and metabolic diseases. Using our proprietary True Single Molecule Sequencing technology (tSMS®), we are able to directly sequence nucleic acids without any PCR amplification. tSMS allows SeqLL to robustly call small changes in mRNA expression (1.2-fold change resolution), while maintaining linear quantification over 5 logs. Since there is no PCR, high or low GC content does not skew the data, rare messages are not lost. Small RNA’s as short as 25 bases are sequenced directly with sensitivity down to picograms of sample. SeqLL generates data that is not possible with other NGS instrument platforms.SeqLL is based in Woburn, MA. Our experienced team of scientists and engineers can help to manage your sequencing project from sample prep through various levels of custom bioinformatics analysis. We will help you learn what is possible with tSMS, and you can ask and answer biological questions previously thought unreachable.